Lung Diseases, Obstructive: all 2,584 studies

Page 26 of 26. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways DiseaseTerminatedNCT00180843Not applicable
• Regulation of the Release of Inflammatory Mediators From Blood LeukocytesWithdrawnNCT00180765
• NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPDCompletedNCT00180635Not applicable
• Markers for Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00180622
• Inhaled Steroid Reduces Systemic Inflammation in COPDCompletedNCT00175565Phase 4
• Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00170222Phase 4
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseCompletedNCT00164138Not applicable
• A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00162864Phase 3
• Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00159549Not applicable
• The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps MuscleCompletedNCT00159367Not applicable
• Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00159341Phase 1
• Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00159289Not applicable
• GR Defect in Sputum Cells in COPDWithdrawnNCT00159276
• GR Defect in Peripheral Blood Mononuclear Cells in COPDWithdrawnNCT00159237
• Modification Of Disease Outcome In COPDTerminatedNCT00158847Phase 4
• Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHFCompletedNCT00156780Phase 1
• Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00153075Phase 4
• Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary DiseaseCompletedNCT00147095
• ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.CompletedNCT00144911Phase 4
• Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144859Phase 2
• Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In ChildrenCompletedNCT00144846Phase 3
• A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144326Phase 3
• The Effect of Cycling Off Criteria During Pressure Support Ventilation in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00141440Not applicable
• Chinese Community Smoking Cessation ProjectCompletedNCT00139516Not applicable
• Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-StudyTerminatedNCT00137956Phase 3
• The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung DiseaseCompletedNCT00136006
• Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2TerminatedNCT00135252Phase 2/3
• Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary DiseaseCompletedNCT00134979Phase 4
• Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)Status unknownNCT00132860Phase 4
• Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00129831Phase 2
• Endobronchial Valve for Emphysema Palliation Trial (VENT)CompletedNCT00129584Phase 3
• Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General PracticeCompletedNCT00128765Not applicable
• Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled TrialStatus unknownNCT00120978Phase 4
• Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPDCompletedNCT00117182Phase 2
• Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease ExacerbationsCompletedNCT00115492Phase 4
• Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )PatientsTerminatedNCT00114426Phase 3
• The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)CompletedNCT00108823Phase 3
• Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary DiseaseCompletedNCT00106821Phase 4
• Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in HispanicsCompletedNCT00106470
• An Evaluation of Home-Based Telemedicine ServicesCompletedNCT00105846Phase 2
• Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT00103922Phase 3
• Internet-Based and Established Dyspnea Self-Management Programs in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00102401Not applicable
• A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight LossCompletedNCT00094562Phase 2
• Disability and Health Outcomes in COPDCompletedNCT00087906
• OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)CompletedNCT00076089Phase 3
• To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDCompletedNCT00064415Phase 3
• Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDCompletedNCT00064402Phase 3
• Supplemental Selenium and Vitamin E and Pulmonary FunctionCompletedNCT00063453Phase 3
• Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)CompletedNCT00062582Phase 3
• A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPDCompletedNCT00056264Phase 3
• Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00051792Phase 1/2
• Chronic Obstructive Pulmonary Disease Gene LocalizationCompletedNCT00037739
• Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary DiseaseCompletedNCT00034112Phase 2
• Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00018408
• Cost-Effectiveness of Lung Volume Reduction SurgeryCompletedNCT00013156Phase 2
• Effectiveness and Cost Impact of a Telecommunications System in COPDCompletedNCT00012805Phase 4
• Assessing the Occupation Burden in COPDCompletedNCT00006513
• Diet and Chronic Obstructive Pulmonary DiseaseCompletedNCT00006419
• Effects of Chronic Ozone Exposure on Lung FunctionCompletedNCT00006306
• Lay-Led Smoking Cessation Approach for Southeast Asian MenCompletedNCT00005720
• Medication Adherence in COPD--A Self-Regulation StudyCompletedNCT00005717
• Intervention for Resistant Pregnant SmokersCompletedNCT00005697
• Genetics of Airway Responsiveness and Lung FunctionCompletedNCT00005537
• Statistical Analysis of Vlagtwedde-Vlaardingen Data SetCompletedNCT00005425
• Sources of Variability in Peak Expiratory FlowCompletedNCT00005382
• Longitudinal Study of Cortisol and Pulmonary FunctionCompletedNCT00005370
• Alpha1-antitrypsin Deficiency RegistryCompletedNCT00005292
• Epidemiology and Pulmonary Response To Organic Dust ExposureCompletedNCT00005288
• Effect of Maternal Smoking On Neonatal Lung FunctionCompletedNCT00005285
• Epidemiology of Airway ResponsivenessCompletedNCT00005284
• Prospective Evaluation of Airways ReactivityCompletedNCT00005282
• Early Risk Predictors For Chronic Pulmonary DiseaseCompletedNCT00005281
• Specialized Center of Research in Occupational and Immunologic Lung DiseaseCompletedNCT00005280
• Tucson Epidemiology Study of Chronic Obstructive Lung DiseasesCompletedNCT00005279
• Honolulu Heart ProgramCompletedNCT00005123
• Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient IndividualsCompletedNCT00001462
• Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)CompletedNCT00000621Phase 2
• National Emphysema Treatment Trial (NETT)CompletedNCT00000606Phase 3
• Emphysema: Physiologic Effects of Nutritional SupportCompletedNCT00000573Phase 2
• Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung DiseaseCompletedNCT00000571Phase 3
• Lung Health Study IICompletedNCT00000569Phase 3
• Lung Health Study (LHS) I and IIICompletedNCT00000568Phase 3
• Clinical Study of Intermittent Positive Pressure Breathing (IPPB)CompletedNCT00000565Phase 3
• Nocturnal Oxygen TherapyCompletedNCT00000564Phase 3

← Lung Diseases, Obstructive overview